Lawrence Eichenfield
Director at Verrica Pharmaceuticals Inc. (VRCA)
Lawrence Eichenfield has filed 11 insider reports with the SEC since June 2021, as director at Verrica Pharmaceuticals Inc. (VRCA) and director at Forte Biosciences, Inc. (FBRX). The latest filing, on June 9, 2026, reports grant or award at Verrica Pharmaceuticals Inc. (VRCA).
- Filings
- 11
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Lawrence Eichenfield is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals Inc. | Director | $3.19 | Jun 9, 2026 | ||||
| FBRX Forte Biosciences, Inc. | Director | Aug 22, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 5, 2026VRCASEC Form 4 filed by Director Eichenfield LawrenceForm 4Grant or award
- Jun 5, 2025VRCASEC Form 4 filed by Director Eichenfield LawrenceForm 4Grant or award
- Aug 20, 2024FBRXSEC Form 4 filed by Director Eichenfield LawrenceForm 4Grant or award
- Jun 6, 2024VRCASEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Sep 19, 2023FBRXSEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Jun 8, 2023VRCASEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Jun 9, 2022VRCASEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Jun 1, 2022FBRXSEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Feb 23, 2022FBRXSEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
- Jun 10, 2021VRCASEC Form 4 filed by Eichenfield Lawrence (Amendment)Form 4Grant or award
- Jun 10, 2021VRCASEC Form 4 filed by Eichenfield LawrenceForm 4Grant or award
Compare Lawrence Eichenfield with
- Lawrence Eichenfield vs Steven Kornfeld1 shared
- Lawrence Eichenfield vs Scott C. Brun1 shared
- Lawrence Eichenfield vs David W Gryska1 shared
- Lawrence Eichenfield vs Richard G Vincent1 shared
- Lawrence Eichenfield vs Barbara K Finck1 shared
- Lawrence Eichenfield vs Shivpreet Singh Kapoor1 shared
Other insiders at the same companies
- Steven KornfeldFBRX
- Scott C. BrunFBRX
- David W GryskaFBRX
- Richard G VincentFBRX
- Barbara K FinckFBRX
- Shivpreet Singh KapoorFBRX
- Stephen K DobersteinFBRX
- Antony A RileyFBRX
- Paul A. WagnerFBRX
- John J. KirbyVRCA
- Jayson RiegerVRCA
- David ZawitzVRCA
- Noah L. RosenbergVRCA
- Diem NguyenVRCA
- Mark A Prygocki SrVRCA
- Gavin CorcoranVRCA
Questions about Lawrence Eichenfield
- What is Lawrence Eichenfield's role at Verrica Pharmaceuticals Inc.?
- Lawrence Eichenfield reports to the SEC as director at Verrica Pharmaceuticals Inc. (VRCA), according to the latest filing on June 9, 2026. Lawrence Eichenfield has also filed as director at Forte Biosciences, Inc. (FBRX).
- Has Lawrence Eichenfield bought or sold stock recently?
- No open-market purchases or sales by Lawrence Eichenfield are on file. The filings report grant or award.
- How do I get alerts when Lawrence Eichenfield files?
- Follow Lawrence Eichenfield on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Lawrence Eichenfield (SEC CIK 0001814892). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR